Ajouter le résultat dans votre panier Faire une suggestion Affiner la recherche Interroger des sources externes
Breastfeeding: A Review of Its Physiology and Galactogogue Plants in View of Traditional Persian Medicine / Roghayeh Javan in Breastfeeding Medicine, Vol 12, n°7 (Septembre 2017)
Titre : Breastfeeding: A Review of Its Physiology and Galactogogue Plants in View of Traditional Persian Medicine Type de document : texte imprimé Auteurs : Roghayeh Javan, Auteur ; Behjat Javadi, Auteur ; Zohre Feyzabadi, Auteur Année de publication : 2017 Article en page(s) : pp. 401-409 Langues : Anglais (eng) Catégories : Galactogogue (plante)
Lactation (thérapeutique non médicamenteuse)
Revue de la littérature
Résumé : "Introduction: The beneficial effects of breastfeeding for the infant and mother are well recognized. Many natural products are reputed to be galactogogue agents in major Traditional Persian Medicine (TPM) textbooks. The aim of this study is to review those medicinal plants that are reported to be effective in increasing breast milk in TPM and to compare the data from TPM texts with the findings of modern pharmacological and clinical research.
Materials and Methods: Data on the medicinal plants used to increase breast milk were obtained from major TPM textbooks. A detailed search in PubMed, Science Direct, Scopus, Google Scholar, and Web of Science databases was performed to confirm the effects of medicinal plants mentioned in TPM on lactation in view of the identified pharmacological actions.
Results: Foeniculum vulgare, Anethum graveolens, Pimpinella anisum, Nigella sativa, and Vitex agnus-castus are among the most effective galactogogue TPM plants. Many pharmacologically relevant activities have been reported for these herbs.
Conclusion: The use of traditional knowledge can pave the way toward finding effective phytopharmaceuticals for increasing breast milk."[résumé de l'auteur]
in Breastfeeding Medicine > Vol 12, n°7 (Septembre 2017) . - pp. 401-409[article]Excrétion lactée du montélukast / Palika Datta in Les Dossiers de l'Allaitement, n°125 (Août 2017)
Titre : Excrétion lactée du montélukast Type de document : texte imprimé Auteurs : Palika Datta, Auteur ; La Leche League France, Auteur Année de publication : 2017 Article en page(s) : pp. 13-14 Langues : Français (fre) Catégories : Asthme
Choix d'un médicament
Composition du lait
Note de contenu : "Le montélukast est un inhibiteur des récepteurs des leucortriènes couramment utilisé dans le traitement prophylactique des crises d'asthme chez les adultes et les enfants à partir de 12 mois (..) mais il n'existe aucune donnée sur son excrétion lactée. Cette étude américaine a mis au point une méthode de quantification du montélukast dans le lait humain." [Extrait de l'article] Permalink :
in Les Dossiers de l'Allaitement > n°125 (Août 2017) . - pp. 13-14[article]Herbal Use During Breastfeeding: LactMed ® Update / Philip O. Anderson in Breastfeeding Medicine, Vol 12, n°9 (Novembre 2017)
Titre : Herbal Use During Breastfeeding: LactMed ® Update Type de document : texte imprimé Auteurs : Philip O. Anderson, Auteur Année de publication : 2017 Article en page(s) : pp. 507-509 Langues : Anglais (eng) Catégories : Difficultés de l'allaitement
Thérapeutique non médicamenteuse
Note de contenu : "Herbal Use During Breastfeeding
Herbal medicine use by nursing mothers raises many issues. The definition of herbal medicines alone can be somewhat problematic. The Dietary Supplement Health and Education Act of 1994 (DSHEA) set up a new regulatory framework for supplements, which are considered as “foods” by the U.S. Food and Drug Administration (FDA). In addition to herbals, dietary supplements include ingredients such as vitamins, minerals, amino acids, and enzymes. Unlike conventional drugs, FDA is not authorized to review dietary supplement products for safety and effectiveness before they are marketed. FDA is responsible for taking action against any adulterated or misbranded dietary supplement product only after it reaches the market.
Some homeopathic drugs are made from plant material and can be mistaken for herbal drugs, but they are not considered dietary supplements. Homeopathic preparations are very dilute. In fact, some have been diluted beyond Avogadro's number and may contain no molecules from the plant.1 Homeopathic drugs can usually be identified by their dilution that is designated by a Roman numeral, usually X (10-fold dilutions) or C (100-fold dilutions). Although the efficacy of homeopathic products beyond a placebo effect is doubtful, there is usually no concern with their use in nursing mothers because of their lack of pharmacologic activity. So, if a woman is taking a homeopathic product labeled as “nux vomica 10x,” it will not harm her breastfed infant, even though nux vomica comes from the plant source of strychnine, Strychnos nux-vomica."
[Extrait de l'artcile]
in Breastfeeding Medicine > Vol 12, n°9 (Novembre 2017) . - pp. 507-509[article]LactMed Update—An Introduction / Philip O. Anderson in Breastfeeding Medicine, Vol. 11, N°2 (Mars 2016)
Titre : LactMed Update—An Introduction Type de document : texte imprimé Auteurs : Philip O. Anderson, Auteur Année de publication : 2016 Langues : Anglais (eng) Catégories : Médicament
Note de contenu : "By way of introduction, I am Philip Anderson, PharmD, the founder in 2003 and principal author of the LactMed® Drugs and Lactation database.1 I am a Health Sciences Clinical Professor of Pharmacy at the University of California, San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences, and a member of the Breastfeeding Medicine editorial board. This column is the first in a series of columns that I will be authoring for Breastfeeding Medicine about the LactMed database. This first column reviews the history, production, features, and proper interpretation of LactMed, and provides tips on how to make best use of the database. Future columns will focus on specific drugs and drug classes, as well as new additions to the database.
The LactMed database contains information on drugs to which breastfeeding mothers may be exposed, and the possible adverse effects of those medications in the nursing infant. LactMed is written under contract with the Specialized Information Services (SIS) Division of the National Library of Medicine (NLM), National Institutes of Health. New information on medication use in nursing mothers is culled from several databases, such as PubMed, Web of Science, and Biosis Previews. The latter two databases are useful for locating data presented at meetings prior to formal publication." [Extrait de l'article, présentation de l'auteur]
in Breastfeeding Medicine > Vol. 11, N°2 (Mars 2016)[article]Medication Information Sources for Breastfeeding Mothers : LactMed ® Update / Philip O. Anderson in Breastfeeding Medicine, Vol 12, n°7 (Septembre 2017)
Titre : Medication Information Sources for Breastfeeding Mothers : LactMed ® Update Type de document : texte imprimé Auteurs : Philip O. Anderson, Auteur Année de publication : 2017 Article en page(s) : pp. 396-397 Langues : Anglais (eng) Catégories : Choix d'un médicament
Connaissances vis à vis de l'allaitement
Note de contenu : "For information on the use and safety of drugs in nursing mothers, the answers you get also depend on where you look for the answers. Several studies have compared the information provided in different sources. A 2007 article found wide variation among sources queried about the advisability of using 14 commonly used drugs during lactation. The most restrictive information came from official drug labeling (e.g., package insert, PDR, DailyMed [https://dailymed.nlm.nih.gov]) and data sources that used labeling as the basis of their information. These sources, which included widely used references, such as Micromedex, ePocrates, and electronic medical record drug databases, listed most or all of the 14 drugs as not safe during lactation. Evidence-based sources including LactMed and Medications and Mother's Milk listed 12 of the 14 drugs as acceptable during breastfeeding (2 of the drugs had not been studied at the time). A 2008 article comparing information on 17 beta-blocking drugs found similar discrepancies. A 2015 article in this journal reviewed recommendations on 11 antihypertensive medications and found that the two evidence-based sources they compared, LactMed and Medications and Mother's Milk, were much more permissive toward breastfeeding during the use of antihypertensives than official labeling. European labeling was even more restrictive than U.S. labeling and it was sometimes internally inconsistent and self-contradictory." [Extrait de l'article] Permalink :
in Breastfeeding Medicine > Vol 12, n°7 (Septembre 2017) . - pp. 396-397[article]Mieux vivre avec notre enfant de la grossesse à deux ans / Nicole Doré
Permalinkn°135 - Juin 2018 (Bulletin de Les Dossiers de l'Allaitement)
PermalinkPharmacokinetics of Teicoplanin in a Breastfeeding Mother / François Fraissinet in Breastfeeding Medicine, Vol. 12, n°4 (Mai 2017)
PermalinkRegional and Facility Differences in Interventions for Mastitis by Australian Physiotherapists / Lara C. Diepeveen in Journal of Human Lactation, Vol. 35, n°4 (Novembre 2019)
PermalinkTreatments for Idiopathic Granulomatous Mastitis: Systematic Review and Meta-Analysis / Xin Lei in Breastfeeding Medicine, Vol 12, n°7 (Septembre 2017)
PermalinkVaccins et immunothérapie / La Leche League France in Les Dossiers de l'Allaitement, HS 2016 (Edition 2016)